# Brimonidine + Timolol

## Combigan 5mL ophthalmic solution

##### 

| Title              | Content                                                                                                                                                                                                                                         |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | ECOMB                                                                                                                                                                                                                                           |
| Indications        | Reduction of elevated intraocular pressure in patients with glaucoma or ocular hypertension.                                                                                                                                                    |
| Dosing             | Instill 1 drop in the affected eye(s) Q12H.                                                                                                                                                                                                     |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                   |
| Contraindications  | Bronchial asthma; a history of bronchial asthma; severe chronic obstructive pulmonary disease; sinus bradycardia; second or third degree atrioventricular block; overt cardiac failure; cardiogenic shock; in patients receiving MAOIs therapy. |
| Adverse Effects    | Conjunctival hyperemiaï¼Œ ocular burning & stinging.                                                                                                                                                                                             |
| Pregnancy          | Human data suggest risk in 2nd and 3 rd trimesters                                                                                                                                                                                              |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                   |

